Citadel Advisors
ERAS icon

Citadel Advisors’s Erasca ERAS Stock Holding History

Citadel Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597K Buy
+36,900
New +$436K ﹤0.01% 8862
2025
Q4 		– Sell
-15,700
Closed -$34.2K – 13002
2025
Q3 		$34.2K Buy
+15,700
New +$25K ﹤0.01% 12358
2025
Q2 		– Sell
-5,700
Closed -$7.81K – 13198
2025
Q1 		$7.81K Sell
5,700
-27,500
-83% -$47.2K ﹤0.01% 13672
2024
Q4 		$83.3K Sell
33,200
-14,200
-30% -$38.9K ﹤0.01% 11735
2024
Q3 		$129K Sell
47,400
-38,700
-45% -$109K ﹤0.01% 10767
2024
Q2 		$203K Buy
86,100
+56,700
+193% +$122K ﹤0.01% 9905
2024
Q1 		$60.6K Buy
29,400
+24,200
+465% +$48.4K ﹤0.01% 11987
2023
Q4 		$11.1K Buy
5,200
+4,600
+767% +$9.7K ﹤0.01% 13061
2023
Q3 		$1.18K Buy
600
+400
+200% +$1.02K ﹤0.01% 13908
2023
Q2 		$552 Buy
200
+100
+100% +$285 ﹤0.01% 14090
2023
Q1 		$301 Sell
100
-1,700
-94% -$6.18K ﹤0.01% 14524
2022
Q4 		$7.76K Buy
+1,800
New +$12.2K ﹤0.01% 13800

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Citadel Advisors's ERAS Position: Q1 2026 in Review

Citadel Advisors reduced its Erasca (ERAS) stake by 52% in Q1 2026, selling an estimated $6.29M and leaving 498,381 shares worth $8.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Citadel Advisors first reported a position in ERAS in Q3 2021 and has held it in 17 quarters since. The position peaked at $11.8M in Q3 2024. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Citadel Advisors held 498,381 shares of Erasca worth $8.06M as of Q1 2026.
  • Citadel Advisors sold 531,964 Erasca shares in Q1 2026, an estimated $6.29M.
  • Erasca made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3569 holding.
  • Citadel Advisors first reported a position in Erasca in Q3 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Erasca position peaked at $11.8M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.